Alderley Analytical Leverages Xevo TQ Absolute XR for Robust Bioanalysis

Alderley Analytical, a key player in the bioanalytical sector, has embraced the latest technological innovations with the introduction of the Xevo TQ Absolute XR Mass Spectrometer from Waters Corporation. This advanced system is designed to tackle high-throughput applications and maintain exceptional performance, even with over 10,000 complex samples processed. Significantly reducing downtime and minimizing energy use, the Xevo TQ Absolute XR offers a substantial leap in analytical robustness, catering to the pressing demands of pharmaceutical companies and regulatory bodies.

In an industry under increasing pressure to adapt to the rigorous demands of pharmaceutical quantitation and PFAS testing, Waters Corporation’s launch of the Xevo TQ Absolute XR Mass Spectrometer could prove transformative. Known for its sensitivity and reliability, this new device outstrips its predecessor by offering a six-fold increase in performance robustness while halving power and nitrogen gas consumption. Packaging all this functionality into a compact design, the Xevo TQ Absolute XR is the epitome of efficiency, effortlessly handling complex matrices without compromising on throughput.

The introduction of the Xevo TQ Absolute XR Mass Spectrometer marks a significant advancement in the field of bioanalysis. With its unprecedented efficiency, sustainability, and reliability, Alderley Analytical and similar laboratories can expect to set new standards in laboratory operations. As the demand for faster and more accurate bioanalytical services escalates, this innovative technology positions Alderley Analytical at the cutting edge of the industry, enabling high-quality and uninterrupted analysis critical for drug development.

For the latest updates and in-depth insights into the world of Analytical Science, including breakthrough treatments, industry trends, and regulatory news, contact Adam Tiberius today!